Menu

Blog

May 1, 2020

ResTORbio pivots pipeline with reverse-merger after trial failure

Posted by in category: biotech/medical

Boston biopharma startup resTORbio Inc. is revamping its pipeline to focus on cancer cell therapies through a reverse-merger.

Leave a reply